Hyderabad startup PopVax works on mRNA cancer vaccine tailored to one patient

Hyderabad-based PopVax is developing a personalised mRNA cancer vaccine for a 34-year-old pancreatic cancer patient, using tumour sequencing to identify targets for treatment.